Don C. Des Jarlais, PhD

Senior Research Fellow at the National Development and Research Institutes

Injection Drug Use and HIV/AIDS; International Intervention Dissemination

headshots-lg-don-de-jarlaisDon C. Des Jarlais, Ph.D. is Director of Research for the Baron Edmond de Rothschild Chemical Dependency Institute at Beth Israel Medical Center, a Senior Research Fellow with the National Development and Research Institutes, Inc. and a Guest Investigator at Rockefeller University in New York. He began his research on AIDS in 1982.

As a leader in the fields of AIDS and injecting drug use, Dr. Des Jarlais has published extensively on these topics including papers in the New England Journal of Medicine, the Journal of the American Medical Association, Science and Nature. He has been particularly active in international research, having collaborated on studies in twenty-five different countries. He serves as a consultant to various institutions, including the Centers for Disease Control and Prevention, the National Institute on Drug Abuse, the National Academy of Sciences and the World Health Organization. He is a former commissioner for the US National Commission on AIDS, and is currently a Core Group Member of the UNAIDS Reference Group on HIV and Injecting Drug Use. In 2010 Dr. Des Jarlais was elected to the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board (SAB).

Selected Publications:

Des Jarlais, D.C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D., & Semaan, S.  (2011). Associations between Herpes Simplex Virus Type 2 and HCV with HIV among Injecting Drug Users in New York City: The Current Importance of Sexual Transmission of HIV.  Am J Public Health, 101(7), 1277-83.

Hagan, H., Pouget, E.R. & Des Jarlais, D.C.  (2011). A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People who Inject Drugs.  J Infect Dis, 204(1), 74-83.

Nelson, P.K., Mathers, B.M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D, & Degenhardt, L.  (2011).  Global Epidemiology of Hepatitis B and Hepatitis C in People who Inject Drugs: Results of Systematic Reviews.  Lancet, Early publication.

Des Jarlais, D.C., Arasteh, K., McKnight, C., Perlman, D., Hagan, H., Semaan, S., & Friedman, S.R.  (2010).  Gender and Age Patterns in HSV-2 and HIV Infection among Non-Injecting Drug Users in New York City.  Sex Transm Dis,  37(10), 637-643.

Des Jarlais, D.C., Arasteh, K., McKnight, C., Ringer, M., & Friedman, S. R.  (2010). Syringe Exchange, Injecting and Intranasal Drug Use.  Addiction, 105(1), 155-158.

Des Jarlais, D.C. (2010).  Learning from HIV Epidemics among Injecting Drug Users. Int J Drug Policy, 21, 97-99.

Des Jarlais, D.C.  (2010). Place, People, Politics and Health.  CMAJ, 182(15), E726-E727.

Des Jarlais, D.C., Arasteh, K., & Gwadz, M. (2010).  Increasing HIV Prevention and Care for Injecting Drug Users.  Lancet, 375 (9719), 961-963.

Des Jarlais, D.C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D.C., Torian, L.V., Beatrice, S., Semaan, S., & Friedman, S.R. (2010).  HIV Infection During Limited Versus Combined HIV Prevention Programs for IDUs in New York City: The Importance of Transmission Behaviors. Drug Alcohol Depend, 109(1-3), 154-160.

Meader, N., Li, R., Des Jarlais, D.C., & Pilling, S. (2010). Psychosocial Interventions for Reducing Injection and Sexual Risk Behaviour for Preventing HIV in Drug Users.  Cochrane Database Syst Rev, 20(1), 1-53.

Semaan, S., Des Jarlais, D.C., Malinowska-Sempruch, K., Kirby, A. & Sharpe, T.T.  (2010). Human Rights and HIV Prevention Among Drug Users.  In: E. Beracochea, C. Weinstein, & D.P. Evans (Eds.). Rights-Based Approaches to Public Health, (pp. 202-220).  New York: Springer Publishing Company.

Semaan, S., Heckathorn, D.D., Des Jarlais, D.C., & Garfein, R.S. (2010). Ethical Considerations in Surveys Employing Respondent-Driven Sampling.  Am J Public Health, 100(4), 582-583.

Wood, E., Werb, D., Kazatchkine, M., Kerr, T., Hankins, C., Gorna, R., Nutt, D., Des Jarlais, D., Barre-Sinoussi, F., & Montaner, J.  (2010). Vienna Declaration: A Call for Evidence-Based Drug Policies.  Lancet, 376(9738), 310-312.

Des Jarlais, DC, Arasteh, A, Hagan, H, McKnight, C, Perlman, DC, & Friedman, SR. (2009). Persistence and change in disparities in HIV infection among injecting drug users in New York City after large-scale syringe exchange.  Am J Public Health, 99(Suppl 2), S445-S451.

Des Jarlais, D.C., McKnight, C., Goldblatt, C., & Purchase, D.  (2009).  Doing Harm Reduction Better: Syringe Exchange in the United States.  Addiction, 104, 1441-1446.

Arasteh, K., & Des Jarlais, D.C. (2008). Injecting Drug Use, HIV, and What to Do About It.  Lancet, 372(9651), 1709-1710.

West, S.G., Duan, N., Peguegnat, W., Gaist, P., Des Jarlais, D.C., Holtgrave, D., Szapocznik, J., Fishbein, M., Rapkin, B., Clatts, M., & Dolan Mullen, P.  (2008). Alternatives to the Randomized Controlled Trial.  Am J Public Health, 98(8), 6-13.